The Stool Biomarkers Test ecosystem comprises a tightly coupled network that begins with upstream raw material suppliers, proceeds through midstream technology development and system integration, and ends with downstream distribution channels and clinical end users. Upstream participants provide reagents, collection devices, and sequencing kits that enable assay construction. Midstream actors—technology providers, instrument manufacturers, and software integrators—assemble these inputs into validated diagnostic platforms. Downstream, distributors, laboratory service firms, and healthcare providers deliver the finished test to clinicians, gastroenterologists, and research institutions, where test results inform patient management and scientific studies. Value is created through the transformation of biological samples into actionable biomarker data and captured via service contracts, reimbursement, and data‑analytics licensing.